All rights reserved. It markets dermatology products, such as Targadox for acne; Exelderm cream for ringworm and jock itch symptoms; Ceracade for dry skin conditions; Luxamend for dressing and managing wounds; Ala-Scalp and Triderm, which are used for the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses; and Ala-Quin, an antibacterial and antifungal cream. Η Yahoo αποτελεί μέρος της Verizon Media. Currently, 3.1% of the shares of the stock are short sold. The official website for Fortress Biotech is www.fortressbiotech.com. Fortress Biotech does not currently pay a dividend. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Do Not Sell My Information. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. (Add your “outperform” vote. © 2020 Cable News Network. The company has collaboration arrangements with some universities, research institutes, and pharmaceutical companies. Top institutional shareholders include Diversified Trust Co (0.01%). View analyst ratings for Fortress Biotech. The company was formerly known as Coronado Biosciences, Inc. and changed its name to Fortress Biotech, Inc. in April 2015. Στοιχεία ελέγχου του ιδιωτικού απορρήτου σας, Πληροφορίες σχετικά με τη συσκευή σας και τη σύνδεσή σας στο διαδίκτυο, συμπεριλαμβανομένης της διεύθυνσης IP, Δραστηριότητα περιήγησης και αναζήτησης κατά τη χρήση των ιστότοπων και των εφαρμογών της Verizon Media. View insider buying and selling activity for Fortress Biotech. View Fortress Biotech's Short Interest. Fortress Biotech has received a consensus rating of Buy. View Fortress Biotech's earnings history. Shares of FBIO can be purchased through any online brokerage account. All times are ET. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Most stock quote data provided by BATS. On average, they expect Fortress Biotech's share price to reach $7.55 in the next year. FBIO stock was acquired by a variety of institutional investors in the last quarter, including Diversified Trust Co. Company insiders that have bought Fortress Biotech stock in the last two years include Lindsay A Md Rosenwald, Malcolm Hoenlein, and Robyn Hunter. Earnings for Fortress Biotech are expected to grow in the coming year, from ($0.93) to ($0.51) per share. Identify stocks that meet your criteria using seven unique stock screeners. The biopharmaceutical company can be reached via phone at 781-652-4500 or via email at [email protected]. Fortress Biotech has a market capitalization of $217.38 million and generates $36.63 million in revenue each year. Disclaimer. View which stocks are hot on social media with MarketBeat's trending stocks report. (Add your “underperform” vote.). As of September 15th, there was short interest totaling 2,030,000 shares, an increase of 48.2% from the August 31st total of 1,370,000 shares. Για να δώσετε τη δυνατότητα στη Verizon Media και τους συνεργάτες μας να επεξεργάζονται τα προσωπικά σας δεδομένα, επιλέξτε 'Συμφωνώ' ή επιλέξτε 'Διαχείριση ρυθμίσεων' για περισσότερες πληροφορίες, καθώς και για να διαχειριστείτε τις επιλογές σας. 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fortress Biotech in the last year. According to analysts' consensus price target of $7.55, Fortress Biotech has a forecasted upside of 189.3% from its current price of $2.61. Specifically, they have bought $1,245,006.00 in company stock and sold $124,611.00 in company stock. Based on aggregate information from My MarketBeat watchlists, some companies that other Fortress Biotech investors own include Sorrento Therapeutics (SRNE), VBI Vaccines (VBIV), Novavax (NVAX), Advanced Micro Devices (AMD), Opko Health (OPK), TG Therapeutics (TGTX), Vaxart (VXRT), NVIDIA (NVDA), Pfizer (PFE) and Dynavax Technologies (DVAX). Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates. © American Consumer News, LLC dba MarketBeat® 2010-2020. CNN Sans™ & © 2016 Cable News Network. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Want to see which stocks are moving? Fortress Biotech had a negative net margin of 124.63% and a negative return on equity of 53.93%. Based on an average trading volume of 1,450,000 shares, the short-interest ratio is presently 1.4 days. Fortress Biotech has only been the subject of 4 research reports in the past 90 days. View our full suite of financial calendars and market data tables, all for free. The biopharmaceutical company had revenue of $9.46 million for the quarter, compared to the consensus estimate of $11.59 million. Post-Market 0.04 (1.49%) Fortress Biotech, Inc. was founded in 2006 and is based in New York, New York. The biopharmaceutical company earns $-39,960,000.00 in net income (profit) each year or ($0.73) on an earnings per share basis. Looking for new stock ideas? Fortress Biotech, Inc. FBIO 2.68 0.11 (4.28%). Morningstar: © 2019 Morningstar, Inc. All Rights Reserved. Company insiders that own Fortress Biotech stock include George Avgerinos, Lindsay A Md Rosenwald, Malcolm Hoenlein and Robyn Hunter. View all competitors. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. All Rights Reserved. 3 Value Stocks that Could Be Making a Comeback, Buy W.W. Grainger (NYSE:GWW) On Post-Earnings Weakness, FDA Approval Means Huge Jump for Gilead Sciences (NASDAQ:GILD), It’s Time To Buy Some Intel (NASDAQ:INTC), 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, 7 Stocks That May Provide the Real Solution to The Coronavirus Puzzle, 7 Stocks That Could Provide a Year-End Rally, 8 Stocks That Robinhood Investors Got Right, 7 Stocks That Will Help You Forget About the Fed, 7 Stocks That Don’t Care Who Wins the Election, 7 Semiconductor Stocks to Power Your Portfolio, Receive Analysts' Upgrades and Downgrades Daily. To see all exchange delays and terms of use please see disclaimer. Learn more. & Director, Project Leader of Inflammatory Bowel Disease, Start Your Risk-Free Trial Subscription Here, PetMed Express (NASDAQ:PETS) Is A High-Yield Value For Income Investors, Hasbro (NASDAQ:HAS) Reports Earnings, It’s Time To Go Toy Shopping. Fortress Biotech's mailing address is 2 GANSEVOORT STREET 9TH FLOOR, NEW YORK NY, 10014. Fortress Biotech does not have a long track record of dividend growth. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Their forecasts range from $4.75 to $10.00. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. FBIO stock was acquired by a variety of institutional investors in the last quarter, including Diversified Trust Co. Company insiders that have bought Fortress Biotech stock in the last two years include Lindsay A Md Rosenwald, Malcolm Hoenlein, and Robyn Hunter. Get short term trading ideas from the MarketBeat Idea Engine. The biopharmaceutical company reported ($0.19) earnings per share for the quarter, topping analysts' consensus estimates of ($0.27) by $0.08. Fortress Biotech's stock was trading at $1.61 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Please log in to your account or sign up in order to add this asset to your watchlist. Fortress Biotech (NASDAQ:FBIO) issued its quarterly earnings results on Monday, August, 10th. Export data to Excel for your own analysis. View our earnings forecast for Fortress Biotech. MarketBeat's community ratings are surveys of what our community members think about Fortress Biotech and other stocks. ), Fortress Biotech has received 263 “underperform” votes. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. In the past three months, Fortress Biotech insiders have bought 899.11% more of their company's stock than they have sold. You may vote once every thirty days. Fortress Biotech's management team includes the following people: Exec. Fortress Biotech is scheduled to release its next quarterly earnings announcement on Tuesday, November 10th 2020. Find real-time FBIO - Fortress Biotech Inc stock quotes, company profile, news and forecasts from CNN Business. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings. Fortress Biotech's stock is owned by many different retail and institutional investors. The company also develops MB-107, a gene therapy for X-linked severe combined immunodeficiency; CAEL-101, a Phase Ia/Ib trial that reduces amyloid deposits in the tissues and organs; CD123 chimeric antigen receptor engineered T-cell (CAR T) program for acute myeloid leukemia; CD20 CAR T program for B cell non-Hodgkin lymphoma; and CS1 CAR T for multiple myeloma and light chain amyloidosis. View insider buying and selling activity for Fortress Biotech. Learn more. Fortress Biotech, Inc. develops and commercializes pharmaceutical and biotechnology products. Since then, FBIO stock has increased by 53.4% and is now trading at $2.47. Find the latest Fortress Biotech, Inc. (FBIO) stock quote, history, news and other vital information to help you with your stock trading and investing. Only 25.76% of the stock of Fortress Biotech is held by institutions. A Warner Media Company. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Some companies that are related to Fortress Biotech include Amgen (AMGN), Gilead Sciences (GILD), Regeneron Pharmaceuticals (REGN), Vertex Pharmaceuticals (VRTX), Biogen (BIIB), Seagen (SGEN), Alexion Pharmaceuticals (ALXN), Immunomedics (IMMU), Incyte (INCY), Exact Sciences (EXAS), Alnylam Pharmaceuticals (ALNY), BioMarin Pharmaceutical (BMRN), Repligen (RGEN), Neurocrine Biosciences (NBIX) and Exelixis (EXEL). Only 29.50% of the stock of Fortress Biotech is held by insiders. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Receive a free world-class investing education from MarketBeat. The P/E ratio of Fortress Biotech is -3.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Oct 21 / Zacks.com - Paid Partner Content, Oct 16 / Zacks.com - Paid Partner Content, Fortress Biotech (FBIO) Enters Oversold Territory.

Rams Vs Seahawks Week 14, Tess Watson, Specimen Days Pdf, Take My Hand It's Time To Leave From Now On To Eternity Song, Thread-waisted Wasp California, Mansions For Sale In Davie, Fl, Nyc News Tips,